Mari / iStockphoto.com
The US Court of Appeals for the Federal Circuit has remanded a decision to the Patent Trial and Appeal Board (PTAB) concerning a dispute between LA Biomedical Research Institute and Eli Lilly.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Federal Circuit, IPR, inter partes review, patent, Eli Lilly, LA Biomedical Research, PTAB, Patent Trial and Appeal Board, Cialis